• Home
  • Media
  • Sitemap
  • About Us
    • The company
      • Brief Profile
      • Vision
      • Mission 2013
      • Key Milestones
      • Board of Directors
      • Key Management Team
    • Parabolic Drugs in News
    • Media Gallery
  •  Our Business
    • CRAMS
      • Infrastructure
      • Capabilities
      • Our Business Model
      • Why PDL?
      • Contact CRAMS Division
    • APIs
      • Segments
      • Manufacturing Facilities
      • Our Products
      • Accreditations
      • Contact us for APIs
    • R & D
      • R&D Centre, Barwala
      • R&D Lab, Derabassi
      • IPR,QA & QC
  •  Global Presence
    • Market Presence
    • Regulatory Affairs
    • Business Opportunities
      • Contract Research
      • Contract manufacturing
      • Strategic tieups for Global Marketing
  • Human Resources
    • HR at PDL
      • HR Vision
      • HR Goals
    • Work with us
      • Current Openings
      • Upload your CV
  • CSR
    • CSR Initiatives
    • Environmental Concern
    • Health and Safety
  • Investor Relations
    • MD's Address
    • Corporate Governance
    • Latest Financial Results
    • Key Financial Indicators
    • Shareholding Pattern
    • Annual Reports
    • Track PDL's Share
    • Contact IR
  • Contact us

 

For more queries related to our CRAMS business:

-USA Office

Malcolm Rosenthal

Executive Vice President- Global Business Development

Parabolic Drugs Limited

119 Watersedge Drive, Toms River,

New Jersey-08753

+1-732-288-0851

+1-848-333-8249

+1-732-678-6362

Email:

mrosenthal@parabolicdrugs.com

-India Office

Shailendra Rastogi

A.G.M.(Business Development)

Parabolic Drugs Ltd,

R&D, Plot no.280-281,HSIIDC, Industrial Area Alipur, Barwala

Distt.Panchkula 131418

Haryana(INDIA)

+91-1733-256380 (Ext.115)

+91-93177-49872

Email:

crams@parabolicdrugs.com

s.rastogi@parabolicdrugs.com

 



Go Back | Home




Parabolic Drugs Limited © 2010 | About Us | Contact us | Sitemap | Privacy Policy